The CRISPR technology has partially restored vision to people with inherited blindness.

Scientists have presented the results of the first phase of clinical trials involving 14 people with inherited blindness, specifically Leber congenital amaurosis. Significant improvements in vision parameters have been observed with the application of CRISPR gene editing technology. Leber congenital amaurosis is characterized by a mutation in the CEP290 gene, resulting in severe vision loss,…

Read More

The first combined vaccine against influenza and COVID-19 has been developed

Scientists at the pharmaceutical company Moderna have developed the first mRNA vaccine targeting both influenza and coronavirus. This combined vaccine successfully completed Phase 3 clinical trials and is awaiting approval from the US regulator FDA. According to Nature, the combined vaccine has shown higher efficacy compared to monovalent vaccines targeting only one virus. mRNA technology…

Read More